Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.
Per-Olof LundgrenBernhard TribukaitAnders KjellmanUlf NormingKiran JagarlmudiOve GustafssonPublished in: The Prostate (2022)
High levels of TK1 predicts death in prostate cancer within 30 years of follow-up.